Back to search

Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice

Data up to Jan 2025

Published1999
Citations48
References47

Total Citations Per Year

Abstract

References (47)

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans

1994 • 3,182 citations

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

1992 • 626 citations

Clinical Experience With Excitatory Amino Acid Antagonist Drugs

1995 • 499 citations

[3H]MK‐801 Labels a Site on the N‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes

1988 • 453 citations

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor

1989 • 434 citations

Glutamate in CNS disorders as a target for drug development: an update

1998 • 423 citations

The behavioral pharmacology of NMDA receptor antagonists

1990 • 331 citations

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

1993 • 318 citations

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies

1997 • 317 citations

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

1995 • 300 citations

Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.

1994 • 283 citations

Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex

1989 • 251 citations

Effects and aftereffects of ibogaine on morphine self-administration in rats

1991 • 194 citations

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

1994 • 183 citations

Cerebrospinal fluid and serum concentrations of the N-methyl-d-aspartate (NMDA) receptor antagonist memantine in man

1995 • 155 citations

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease

1992 • 137 citations

Regional Variations in the Pharmacology of NMDA Receptor Channel Blockers: Implications for Therapeutic Potential

1995 • 137 citations

Effects of ibogaine on acute signs of morphine withdrawal in rats: Independence from tremor

1992 • 119 citations

Medication development of ibogaine as a pharmacotherapy for drug dependence.

1998 • 117 citations

Different binding affinities of NMDA receptor channel blockers in various brain regions—Indication of NMDA receptor heterogeneity

1995 • 115 citations

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

1995 • 109 citations

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence

1996 • 105 citations

Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.

1997 • 102 citations

N-Methyl-d-aspartic acid-induced lethality in mice: selective antagonism by phencylidine-like drugs

1988 • 97 citations

NMDA antagonist properties of the putative antiaddictive drug, ibogaine.

1995 • 93 citations

Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination.

1994 • 92 citations

The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

1994 • 92 citations

Mechanisms of antiaddictive actions of ibogaine.

1998 • 88 citations

Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures.

1992 • 85 citations

Sensitive and rapid behavioral differentiation ofN-methyl-d-aspartate receptor antagonists

1994 • 83 citations

Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D- aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine.

1991 • 59 citations

Dizocilpine-like Discriminative Stimulus Effects of Low-affinity Uncompetitive NMDA Antagonists

1996 • 59 citations

Ibogaine block of the NMDA receptor: In vitro and in vivo studies

1996 • 53 citations

Amantadine and the glutamate hypothesis of schizophrenia Experiences in the treatment of neuroleptic malignant syndrome

1993 • 44 citations

Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.

1999 • 40 citations

Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.

1998 • 36 citations

Synthesis and structure-activity relationship of C5-substituted analogs of (.+-.)-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine [(.+-.)-desmethyl-MK801]: ligands for the NMDA receptor-coupled phencyclidine binding site

1990 • 35 citations

Receptor Mediation of the Discriminative Stimulus Properties of Phencyclidine and Sigma-Opioid Agonists

1988 • 34 citations

Memantine has phencyclidine-like but not cocaine-like discriminative stimulus effects in rats

1992 • 28 citations

The discriminative stimulus effects of MK-801: Generalization to other N-methyl-D-aspartate receptor antagonists

1989 • 23 citations

Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain.

1998 • 22 citations

Evaluation of ADCI against convulsant and locomotor stimulant effects of cocaine: Comparison with structural analogs dizocilpine and carbamazepine

1994 • 19 citations

The Effects of Sigma, PCP, and Opiate Receptor Ligands in Rats Trained With Ibogaine as a Discriminative Stimulus

1998 • 16 citations

Ibogaine attenuates morphine-induced conditioned place preference.

1995 • 15 citations

Ibogaine fails to interrupt the expression of a previously established one-trial morphine place preference

1996 • 12 citations

Failure of Ibogaine to Produce Phencyclidine-Like Discriminative Stimulus Effects in Rats and Monkeys

1998 • 11 citations

Neurochemical and neuroendocrine effects of ibogaine in rats: comparison to MK-801.

1998 • 10 citations

Cited By (0)

Loading...
Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA… (1999) – Psychopharmacology | Metascience Observatory Explorer